PPM-204

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Diabetes Mellitus

Phase 1

Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart

CompletedNCT00447629

Wyeth is now a wholly owned subsidiary of PfizerDiabetes Mellitus

Start: 2007-01-31End: 2007-03-31Updated: 2007-12-05

Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects

CompletedNCT00448032

Wyeth is now a wholly owned subsidiary of PfizerDiabetes Mellitus

Start: 2006-11-30End: 2007-03-31Updated: 2007-12-05

Phase 2

Study Evaluating PPM-204 In Subjects With Type 2 Diabetes

TerminatedNCT00425919

Wyeth is now a wholly owned subsidiary of PfizerDiabetes Mellitus

Start: 2007-01-31End: 2007-10-31Target: 500Updated: 2007-12-27